Korea S.E.
03:30:00 13/05/2024 am IST
5-day change
1st Jan Change
8,100
KRW
+2.40%
+1.12%
-24.30%
CTCBIO Inc. announced that it has received KRW 9.999985977 billion in funding from Bridge Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
On April 1, 2021, CTCBIO Inc. (KOSDAQ:A060590) closed the transaction.
Korean Sugar Imports Plunge 14% as Diabetes Cases Surge
24/04
MT
CTCBIO Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
21/03
CI
An unknown buyer agreed to acquire an unknown minority stake in CTCBIO Inc. for KRW 20 billion.
16/23/16
CI
CTCBIO Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
12/23/12
CI
An unknown buyer agreed to acquire 12.57229% stake in CTCBIO Inc. for KRW30 billion.
31/23/31
CI
CTCBIO Inc. announced that it has received KRW 9.999985977 billion in funding from Bridge Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
01/21/01
CI
CTCBIO Inc. announced that it expects to receive KRW 9.999985977 billion in funding from Bridge Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
22/21/22
CI
CTCBIO Inc. announced that it has received KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Daewoo Co., Ltd., Shinhan Financial Investment Co., Ltd
25/20/25
CI
CTCBIO Inc. announced that it expects to receive KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Daewoo Co., Ltd., Shinhan Financial Investment Co., Ltd
23/20/23
CI
CTCBIO Inc. announced that it has received KRW 21 billion in funding from NH Investment & Securities Co., Ltd., Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., KB Securities Co.,Ltd, Mirae Asset Daewoo Co., Ltd., Shinhan Investment Corp.
04/18/04
CI
CTCBIO Inc. announced that it expects to receive KRW 21 billion in funding from NH Investment & Securities Co., Ltd., Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., KB Securities Co.,Ltd, Mirae Asset Daewoo Co., Ltd., Shinhan Investment Corp. other investors
02/18/02
CI
CTCBIO Inc. announced that it has received KRW 20 billion in funding from Korea Investment Partners Co. Ltd.
25/17/25
CI
CTCBIO Inc. announced that it expects to receive KRW 20 billion in funding from Korea Investment Partners Co. Ltd. and other investors
22/17/22
CI
CTCBIO., Inc.'s Equity Buyback announced on August 8, 2014 has expired.
04/15/04
CI
CTCBIO., Inc.(KOSDAQ:A060590) added to Russell Global Index
29/15/29
CI
Ferring Pharmaceuticals Acquires Novel Drug Delivery Technology from CTCBIO Inc
23/15/23
CI
CTCBIO., Inc.'s Equity Buyback Plan Extended till August 4, 2015.
05/15/05
CI
CTCBIO., Inc. cancelled the acquisition of a Factory in Ansan City from SK Chemicals Ltd.
17/14/17
CI
Tranche Update on CTCBIO., Inc.'s Equity Buyback Plan announced on August 8, 2014.
11/14/11
CI
CTCBIO., Inc. acquired drug manufacturing division of SK Chemicals Co.,Ltd.
29/14/29
CI
CTCBIO., Inc.'s Equity Buyback announced on August 22, 2013 has expired with 130,811 shares, representing 0.75% for KRW 2,907.19 million.
21/14/21
CI
Tranche Update on CTCBIO., Inc.'s Equity Buyback Plan announced on August 22, 2013.
21/14/21
CI
CTCBIO., Inc. announces an Equity Buyback for KRW 3,000 million worth of its shares.
08/14/08
CI
CTCBIO., Inc. authorizes a Buyback Plan.
08/14/08
CI
Tranche Update on CTCBIO., Inc.'s Equity Buyback Plan announced on August 22, 2013.
22/13/22
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
CTCBIO Inc. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals, veterinary drugs, animal feed supplements and functional foods. It pharmaceuticals include anticancer agents, antibiotics, bone injury treatments, antiulcer agents, blood flow stimulants and others. Its veterinary drugs include vaccines, antibiotics, immune enhancers, enzymes, organic acid, avian influenza-related agents and others. Its animal feed supplements include pigments, kapok seed meal, sesame meal and others. Its functional food business includes the development and manufacture of enzymes, lactobacillus and related products mainly used in dairy products. It also involves in the development of pharmaceutical manufacturing technology and know-how. The Company distributes its products within domestic market and to overseas markets.
More about the company
1st Jan change
Capi.
-24.30% 14Cr -14.93% 7.71TCr +26.62% 378.97Cr -0.14% 321.81Cr +16.05% 163.67Cr -7.99% 149.65Cr -22.43% 129.74Cr -4.69% 125.01Cr -9.08% 118Cr +5.25% 110.24Cr
Veterinary Drugs
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
CTCBIO INC. 